| Prof Steven Wise |
| The University of Sydney |
| Cardiovascular |
| Treatment |
Key achievements to date:
- Successful establishment of spin-off company NanomedX with private seed funding of over $790,000
- Sydney Local Health District – Accelerating Translation of New Cardiovascular Devices and Materials, $361,752
- Heart Foundation Future Leader Fellow Level 3, $593,126
- NSW Cardiovascular Initiative, $727,423
- MTPConnect TTRA Research Project, $739,128
- NSW Cardiovascular Senior Scientist Grant, $746,488
- University of Sydney FMH Biomanufacturing Incubator, $250,000
- MRFF/TTRA Program, $750,000 Tranche A investment to help drive the innovation towards human trials, as well as a further $375,000 available if milestones are met.